TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Novo Nordisk Pharmatech A/S
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
880,400
|
598,265
|
619,083 |
| Earnings before taxes |
98,691
|
49,255
|
146,708 |
| Total assets |
1,266,562
|
966,914
|
639,924 |
| Current assets |
632,917
|
503,716
|
247,023 |
| Current liabilities |
458,447
|
234,231
|
90,539 |
| Equity capital |
766,912
|
689,619
|
520,247 |
| - share capital |
10,001
|
10,001
|
10,000 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
60.6%
|
71.3%
|
81.3% |
| Turnover per employee |
5,869
|
3,988
|
4,127 |
| Profit as a percentage of turnover |
11.2%
|
8.2%
|
23.7% |
| Return on assets (ROA) | |||
| Current ratio |
138.1%
|
215.1%
|
272.8% |
| Return on equity (ROE) |
12.9%
|
7.1%
|
28.2% |
| Change turnover |
282,135
|
-20,818
|
-48,646 |
| Change turnover % |
47%
|
-3%
|
-7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.